Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133944) titled 'Low-dose aspirin for the prevention of tumor recurrence and metastasis after liver transplantation for hepatocellular carcinoma' on Oct. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
Recurrence and metastasis of hepatocellular carcinoma after liver transplantation
Intervention:
Control group / Non-aspirin group:Standard postoperative immunosuppressive regimen, with no additional interventions
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Control group...